Long Straddle on Novo Nordisk A/S
Complete example: Long Straddle on Novo Nordisk (NVO) — including strikes, premium, break-even, and interactive payoff diagram.
Novo Nordisk A/S for Options Traders
Novo Nordisk A/S is the Danish pharma giant behind the GLP-1 blockbusters Ozempic and Wegovy, and one of Europe's most valuable companies. US options are accessible via its NYSE-listed ADRs (ticker NVO). News on trials, competition (Eli Lilly) and manufacturing capacity pushes volatility to an elevated level (IV 30-52%) — attractive for premium strategies with clearly defined risk.
Long Straddle — Quick Overview
The long straddle simultaneously buys an ATM call and an ATM put with the same strike and expiration date. The strategy profits from large price movements in either direction — whether the price rises or falls sharply. Maximum loss is the total debit paid. Particularly popular before binary events like quarterly earnings, central bank decisions, or major product announcements.
Advantages
- Profits from strong moves in either direction
- Clearly defined maximum loss (total debit paid)
- No directional prediction required
- Benefits from IV increase (positive vega)
Disadvantages
- Expensive: ATM options have the highest time value premium
- Time decay works strongly against you if the stock stays flat
- IV compression after earnings can significantly devalue the position
- Stock must move more than IV implies to be profitable
Long Straddle on Novo Nordisk
Illustrative example based on a typical Novo Nordisk price of $85,00. Strikes and premiums are indicative — actual market prices will vary.
| Position | Type | Strike | Action | Premium |
|---|---|---|---|---|
| Long Call (ATM) | Call | $85,00 | Buy (debit) | -$2,98 |
| Long Put (ATM) | Put | $85,00 | Buy (debit) | -$2,98 |
| Net debit paid | -$5,95 (-$595 per contract) | |||
Payoff Diagram at Expiration
Profit and loss of the Long Straddle on Novo Nordisk depending on the price at expiration. Values per contract (100 shares).
Why Long Straddle for Novo Nordisk?
Medium volatility offers a balanced straddle setup: not too expensive to buy, but sufficient premium on both sides. Breakeven points typically sit 5-8% from the strike — realistic when a significant event is approaching. Close straddles no later than 48 hours before an earnings event or shortly after.
When is the right time?
- 1Strong binary event expected (earnings, FDA, M&A, central bank decision)
- 2IV currently low relative to historical volatility
- 3No clear directional expectation, but strong movement anticipated
- 4Stock historically makes larger earnings moves than IV implies
- 5Short to medium term (7-45 days to expiration)
Why Novo Nordisk for Options Traders
Novo Nordisk is one of Europe's most valuable companies and the market leader in GLP-1 drugs (Ozempic, Wegovy). Liquid US options are accessible via its NYSE-listed ADRs (ticker NVO). IV is elevated at typically 30-52%, driven by trial data, competition (Eli Lilly) and manufacturing capacity. For options traders NVO is an underlying with solid premiums and a clear fundamental story — suitable for defined-risk premium strategies.
Historical Context
Novo Nordisk saw an exceptional re-rating in 2021-2023 as Ozempic and Wegovy opened up the obesity market. Sharp pullbacks followed as disappointing trial data (including on next-generation drugs) and growing competitive pressure from Eli Lilly weighed on the valuation. These swings between euphoria and disappointment produce recurring IV spikes around trial results and quarterly reports. Traders should keep the calendar of clinical data and approval decisions in view.
FAQ: Long Straddle on Novo Nordisk
How do I trade Novo Nordisk options as a German investor?
What drives volatility on Novo Nordisk?
Is NVO suitable for conservative income strategies?
Long Straddle on other stocks
Other strategies for Novo Nordisk
Want to try this strategy yourself?
Use our free options tools for your own calculations — or discover more strategies on Novo Nordisk and other underlyings.